Login
Search
Search
0 Dates
2026
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
CPC 2026
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
The Role of Phase III Cardiac Rehabilitation in Sustaining Exercise Capacity and Quality of Life: a One-Year Cohort Study
Session:
Sessão de Posters 36 - Reabilitação para todos: equidade, inovação e impacto a longo prazo
Speaker:
Filipa Cazeiro
Congress:
CPC 2026
Topic:
J. Preventive Cardiology
Theme:
29. Rehabilitation and Sports Cardiology
Subtheme:
29.2 Cardiovascular Rehabilitation
Session Type:
Posters Eletrónicos
FP Number:
---
Authors:
Filipa Cazeiro; Catarina Silva; Daniel Inácio Cazeiro; Madalena Lemos Pires; Mariana Borges; Gonçalo Sá; Fausto J Pinto; Ana Abreu; Rita Pinto
Abstract
<p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Aptos,sans-serif"><strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">Introduction: </span></span></span></strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">Cardiac rehabilitation (CR) is a cornerstone of secondary prevention for cardiovascular disease (CVD) patients, improving functional capacity, quality of life (QoL), and long-term outcomes. While the benefits of phase II CR are well established, evidence on the impact of phase III CR programs remains limited.</span></span></span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Aptos,sans-serif"><strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">Purpose: </span></span></span></strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">To evaluate the effects of a maintenance phase III CR program on QoL and functional capacity over 1 year.</span></span></span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Aptos,sans-serif"><strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">Methods: </span></span></span></strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">Single-centre prospective cohort study including CVD patients enrolled in a phase III supervised exercise-based community CR program (2/3x per week, combined training 60 min). Clinical data, cardiopulmonary exercise test (CPET) results, and 36-Item Short Form Survey (SF-36) responses were collected at baseline and at 1-year follow-up. </span></span></span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Aptos,sans-serif"><strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">Results</span></span></span></strong><strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">: </span></span></span></strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">Our cohort included 99 patients (79.8% male; mean age 61.1</span></span></span><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">±10.2 years</span></span></span><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">, 15.1% type II diabetes). The majority (85.9%) were referred after an acute coronary syndrome.</span></span></span><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black"> Most participants (86.7%) attended phase III sessions 3 x/week</span></span></span><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">.</span></span></span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Aptos,sans-serif"><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">Analysis of QoL revealed significant improvements at 1-year follow-up in several domains, including general health (59.6±17.8 to 63.7±20.2, p=.005), role-physical (77.5±34.2 to 84.9±29.0, p=.028), physical functioning (79.2±17.3 to 84.7±16.8, p<.001), and the physical component summary score (49.5±9.5 to 51.6±9.7, p=.008). Conversely, the bodily pain score decreased (78.1±20.7 to 74.1±23.6, p=.049).</span></span></span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Aptos,sans-serif"><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">Attending the program 3x/week resulted in greater gains in peak workload (17.0±21.5 vs 7.3±15.4 W, p=.002) and peak VO2 (1.7±3.4 vs 0.5±3.2 mL/kg/min, p=.046) at 1 year. Younger patients (<62 years) showed greater gains in general health (5 [0,16] vs 0 [-7,10], p=.016) and mental health (4 [0, 8] vs 0 [-8, 8], p=.046), as well as in CPET performance (peak workload p=.003; peak VO2 p=.023).</span></span></span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Aptos,sans-serif"><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">Diabetic patients showed worsening in physical functioning </span></span></span><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">(–5 [-15, 5] vs. 5 [0, 15], p=.032) and social functioning (–9.2±16.1 vs. 2.2±14.8; p=.008). Both diabetic and non-ischemic patients demonstrated less improvement in peak workload (5 [0, 17] vs. 12W [1, 25], p=.055; 0 [-9, 14.3] vs 11W [2, 25], p=.01, respectively).</span></span></span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Aptos,sans-serif"><strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">Conclusions</span></span></span></strong><strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black">:</span></span></span></strong><span style="font-size:11.0pt"><span style="font-family:"Calibri",sans-serif"><span style="color:black"> Phase III CR yields lasting gains in physical function, exercise capacity, and QoL. Attending 3x/week supports sustained improvement, especially in younger patients, while some high-risk groups may require tailored care. Overall, structured phase III CR remains essential for continued cardiac recovery and secondary prevention.</span></span></span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site